Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35375
NL-OMON35375
Recruiting
Phase 2

Stereotactic Radiotherapy for Metastasis to the Lung - Stereotactic Radiotherapy for Metastasis to the Lung

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionslung cancerlung malignancy100386661002910710038737

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
lung cancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •The patient is eighteen years or older.
  • •The metastases are limited to a maximum of 2 organs, and one of the 2 is the lung.
  • •The patient has no more than 5 metastatic lesions.
  • •The primary tumor site is locally controlled.
  • •The interval between treatment of the primary tumor and diagnosis of the metastasis is at least four months.
  • •The patient has a life expectancy of at least 6 months.

Exclusion Criteria

  • •Patients with more than 5 metastatic lesions.
  • •Patients with an active primary tumor site.
  • •pregnant women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Stereotactic ablative radiation against metastatic lesion detected by DWIBS for High risk Prostate CancerProstate cancer
JPRN-UMIN000044546Mie University10
Not yet recruiting
Not Applicable
Indication for stereotactic radiotherapy of the macula with IRay® for wet age-related macular degeneratioH35.3Degeneration of macula and posterior pole
DRKS00009593niversitäts-Augenklinik Freiburg800
Completed
Phase 2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476
NL-OMON37922Vrije Universiteit Medisch Centrum20
Completed
Phase 2
Stereotactic body radiotherapy followed by surgical stabilization for patients with painful unstable spinal metastases: First-in-man study according to the IDEAL recommendationsmetastatic spine tumorspinal metastases100059591002747610005944
NL-OMON42087niversitair Medisch Centrum Utrecht13
Completed
Phase 2
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastases
JPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90